HQL Price Forecast & CEF Analysis. Distribution · NAV · Discount · Expense Ratio · RSI · MACD | US Stocks Today
Full metrics table
애브어르디엔 라이프 사이언스 인베스터스HQL | NYSE | Equity fund 🧬 A closed-end fund (CEF) specializing in life sciences managed by Aberdeen, this product seeks long-term capital appreciation by investing in healthcare companies such as biotechnology, pharmaceuticals, and diagnostics, while paying out quarterly distributions. As it focuses on the life sciences sector, it is highly susceptible to industry cycles.
Against the value of what the fund holds it trades about at value.
Its holdings are worth $18.32 per share, but it trades at $17.98. Over the past year it usually traded 8.9% below value, so it is pricier now.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
Traded about as much as usual. That is 98% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -14.1%. The S&P 500 did +62% over the same period.
Tap to view numbers
Dividends are paid consistently
Pays 12.36% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 38.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #618 of 1436 in the industry
Based on market cap of $551M.
BSVN#617 Bank7 Corp $553M PER 13.5 HQL#618 abrdn Life Sciences Investors $551M PER - 
BSRR#620 Sierra Bancorp $545M PER 10.9 
NPB#621 Northpointe Bancshares Inc $545M PER 7.4 
COFS#622 Choiceone Financial Services Inc $542M PER 10.0 
FAQ
What kind of CEF is HQL?
HQL is a closed-end fund (CEF).
What is the distribution yield of HQL?
HQL's distribution yield is approximately 12.36%, paid out on a regular basis.
What is the 52-week high and low for HQL?
HQL has recorded a 52-week high of $22.67 and a low of $15.66.
